Open AccessA Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
Author(s) -
William A. Fischer,
Joseph J. Eron,
Wayne Holman,
M.S. Cohen,
Lei Fang,
Laura J. Szewczyk,
Timothy P. Sheahan,
Ralph S. Baric,
Katie R. Mollan,
Cameron R. Wolfe,
Elizabeth R. Duke,
Masoud Azizad,
Katyna Borroto–Esoda,
David A. Wohl,
Robert W. Coombs,
Amy James Loftis,
Paul Alabanza,
Felicia Lipansky,
Wendy Painter
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/dmx8-nb74
Subject(s) - covid-19 , virology , rna , virus , biology , medicine , infectious disease (medical specialty) , outbreak , genetics , disease , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom